Ocugen Inc Stock Analysis
OCGN Stock | USD 1.18 0.07 5.60% |
Ocugen Inc is overvalued with Real Value of 1.02 and Target Price of 4.0. The main objective of Ocugen stock analysis is to determine its intrinsic value, which is an estimate of what Ocugen Inc is worth, separate from its market price. There are two main types of Ocugen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Ocugen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Ocugen's stock to identify patterns and trends that may indicate its future price movements.
The Ocugen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Ocugen is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Ocugen Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ocugen's ongoing operational relationships across important fundamental and technical indicators.
Ocugen |
Ocugen Stock Analysis Notes
The company recorded a loss per share of 0.26. Ocugen Inc last dividend was issued on the 30th of September 2019. The entity had 1:60 split on the 30th of September 2019. Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. Ocugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To find out more about Ocugen Inc contact Shankar MBA at 484 328 4701 or learn more at https://www.ocugen.com.Ocugen Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ocugen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ocugen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ocugen Inc is way too risky over 90 days horizon | |
Ocugen Inc may become a speculative penny stock | |
Ocugen Inc appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 6.04 M. Net Loss for the year was (63.08 M) with loss before overhead, payroll, taxes, and interest of (49.76 M). | |
Ocugen Inc currently holds about 101.6 M in cash with (62.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.46. | |
Latest headline from benzinga.com: INVESTOR DEADLINE APPROACHING Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen |
Ocugen Inc Upcoming and Recent Events
Earnings reports are used by Ocugen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ocugen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024 Upcoming Quarterly Report | View | |
3rd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Ocugen Largest EPS Surprises
Earnings surprises can significantly impact Ocugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2023-08-21 | 2023-06-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2022-08-05 | 2022-06-30 | -0.08 | -0.09 | -0.01 | 12 |
Ocugen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ocugen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ocugen Inc backward and forwards among themselves. Ocugen's institutional investor refers to the entity that pools money to purchase Ocugen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 296.2 K | Cubist Systematic Strategies, Llc | 2023-12-31 | 265.5 K | Renaissance Technologies Corp | 2023-12-31 | 246.2 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 187.1 K | Jpmorgan Chase & Co | 2023-12-31 | 182.8 K | Charles Schwab Investment Management Inc | 2023-12-31 | 170.3 K | Two Sigma Investments Llc | 2023-12-31 | 157.3 K | Bank Of America Corp | 2023-12-31 | 155.2 K | D. E. Shaw & Co Lp | 2023-09-30 | 139 K | Vanguard Group Inc | 2023-12-31 | 12 M | Blackrock Inc | 2023-12-31 | 3.7 M |
Ocugen Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 321.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ocugen's market, we take the total number of its shares issued and multiply it by Ocugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Ocugen Profitablity
Ocugen's profitability indicators refer to fundamental financial ratios that showcase Ocugen's ability to generate income relative to its revenue or operating costs. If, let's say, Ocugen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Ocugen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Ocugen's profitability requires more research than a typical breakdown of Ocugen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.98) | (1.03) | |
Return On Capital Employed | (1.38) | (1.45) | |
Return On Assets | (0.98) | (1.03) | |
Return On Equity | (1.56) | (1.48) |
Management Efficiency
Ocugen Inc has return on total asset (ROA) of (0.473) % which means that it has lost $0.473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1014) %, meaning that it created substantial loss on money invested by shareholders. Ocugen's management efficiency ratios could be used to measure how well Ocugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to drop to -1.03. In addition to that, Return On Capital Employed is likely to drop to -1.45. At this time, Ocugen's Non Current Assets Total are very stable compared to the past year. As of the 24th of April 2024, Non Currrent Assets Other is likely to grow to about 3.5 M, while Total Assets are likely to drop about 48.2 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.17 | 0.16 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 0.17 | 0.16 | |
Enterprise Value Over EBITDA | (1.67) | (1.75) | |
Price Book Value Ratio | 3.46 | 3.64 | |
Enterprise Value Multiple | (1.67) | (1.75) | |
Price Fair Value | 3.46 | 3.64 | |
Enterprise Value | 108 M | 171.3 M |
The analysis of Ocugen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Ocugen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Ocugen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 3.743 |
Technical Drivers
As of the 24th of April, Ocugen holds the Semi Deviation of 6.05, coefficient of variation of 498.08, and Risk Adjusted Performance of 0.1345. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocugen, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Ocugen Inc, which can be compared to its competitors. Please check Ocugen Inc jensen alpha and downside variance to decide if Ocugen Inc is priced some-what accurately, providing market reflects its current price of 1.18 per share. Given that Ocugen is a hitting penny stock territory we advise to closely look at its total risk alpha.Ocugen Inc Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ocugen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ocugen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Ocugen Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ocugen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ocugen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ocugen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Arun Upadhyay over three months ago Payment of 41633 shares by Arun Upadhyay of Ocugen subject to Rule 16b-3 | ||
Arun Upadhyay over three months ago Acquisition by Arun Upadhyay of 137795 shares of Ocugen subject to Rule 16b-3 | ||
Zhang Junge over six months ago Exercise of in-the-money or at-the-money derivative position by Zhang Junge of 1653 shares of Ocugen | ||
Arun Upadhyay over six months ago Payment of 842 shares by Arun Upadhyay of Ocugen subject to Rule 16b-3 | ||
Zhang Junge over six months ago Purchase by Zhang Junge of 200278 shares of Ocugen | ||
Vu Quan Anh over a year ago Ocugen exotic insider transaction detected |
Ocugen Predictive Daily Indicators
Ocugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ocugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 794965.0 | |||
Daily Balance Of Power | (0.50) | |||
Rate Of Daily Change | 0.94 | |||
Day Median Price | 1.22 | |||
Day Typical Price | 1.21 | |||
Price Action Indicator | (0.07) | |||
Period Momentum Indicator | (0.07) |
Ocugen Forecast Models
Ocugen's time-series forecasting models are one of many Ocugen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ocugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Ocugen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Ocugen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ocugen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ocugen. By using and applying Ocugen Stock analysis, traders can create a robust methodology for identifying Ocugen entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (10.45) | (10.97) | |
Operating Profit Margin | (10.86) | (11.40) | |
Net Loss | (10.45) | (10.97) | |
Gross Profit Margin | 0.88 | 0.62 |
Current Ocugen Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ocugen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ocugen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
4.0 | Strong Buy | 3 | Odds |
Most Ocugen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ocugen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ocugen Inc, talking to its executives and customers, or listening to Ocugen conference calls.
Ocugen Stock Analysis Indicators
Ocugen Inc stock analysis indicators help investors evaluate how Ocugen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ocugen shares will generate the highest return on investment. By understating and applying Ocugen stock analysis, traders can identify Ocugen position entry and exit signals to maximize returns.
Begin Period Cash Flow | 77.6 M | |
Long Term Debt | 2.8 M | |
Common Stock Shares Outstanding | 244.3 M | |
Total Stockholder Equity | 40.6 M | |
Property Plant And Equipment Net | 17.3 M | |
Cash And Short Term Investments | 39.5 M | |
Cash | 39.5 M | |
Accounts Payable | 3.2 M | |
Net Debt | -32.5 M | |
50 Day M A | 1.2307 | |
Total Current Liabilities | 17.1 M | |
Other Operating Expenses | 71.6 M | |
Non Current Assets Total | 21.6 M | |
Forward Price Earnings | 15.2207 | |
Non Currrent Assets Other | 3.4 M | |
Stock Based Compensation | 9.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 0.025 | Quarterly Revenue Growth 1.426 | Return On Assets (0.47) | Return On Equity (1.10) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.